Apotex Corp. recalls Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
- Products
-
- Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution
- Company
- Apotex Corp.
- Where it was sold
-
Nationwide in the US
Nationwide
- Units affected
- 151,034 bottles
- About this recall
- Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1 (5 mL), NDC 60505-0589-2 (10 mL).